Clinical Trial Update: Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating tight control of blood glucose during Hyper-CVAD chemotherapy for acute lymphoblastic leukemia; the study was terminated and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• CYTARABINE (CYTARABINE)
• DEXAMETHASONE (Dexamethasone)
• Doxorubicin (doxorubicin)
• METHOTREXATE (METHOTREXATE)
• Vincristine (vincristine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Lymphoma | Phase 3 | Status: TERMINATED | Results posted: 2014-08-07